BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 15, 2008
View Archived Issues
Amarin Adds $28M to Support CNS, Cardiovascular Pipeline
Amarin Corp. plc, which rebounded from dismal Huntington's disease data with the December acquisition of Ester Neurosciences Ltd., is moving full steam ahead once again, thanks to a $28 million cash infusion. (BioWorld Today)
Read More
Wall Street Analysts Prepare for ASCO Flood Starting Friday
Read More
ApoD: Is it Toxic, Or a Life-Extender?
Read More
Lawmakers Debate FDA Liability Preemption Rules
Read More
FDA Places Hold on Geron's Cell Therapy, CEO 'Disappointed'
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Clinic Roundup
Read More
Earnings Roundup
Read More